FIRVANQ

What this means for you

Registered since 24 Jul 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Jul 2028: the §8 & §9 renewal).

Record

Serial number

87451656

Registration number

5525903

Mark type

Word mark

Filed

16 May 2017

Published for opposition

17 Oct 2017

Registered

24 Jul 2018

Next maintenance filing

§8 & §9 renewal, due by 24 Jul 2028 (grace period to 24 Jan 2029)

Attorney of record

Douglas R. Wolf

Goods and services

• Class 005 — Pharmaceuticals: antibiotics; pharmaceutical preparations, namely, vancomycin for the treatment of colitis and gastrointestinal disorders in oral solution form, powder form and diluent form; pharmaceutical preparations, namely, vancomycin for the treatment of clostridium difficile and staphylococcus aureus colitis in oral solution form, powder form and diluent form

Owner

• AZURITY PHARMACEUTICALS, INC., WOBURN, MA
• CutisPharma, Inc., Woburn, MA
• CutisPharma, Inc., Wilmington, MA
• CutisPharma, Inc., Wilmington, MA

Prosecution history

• 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 12 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 12 Sept 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 12 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 04 Mar 2024 — TEAS SECTION 8 & 15 RECEIVED
• 24 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 29 Apr 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 23 May 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 23 May 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 26 Mar 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 26 Mar 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 24 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
• 20 Jun 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 19 Jun 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 31 May 2018 — STATEMENT OF USE PROCESSING COMPLETE